Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to AzolesIn VitroandIn Vivoin a Murine Model of Experimental Vaginitis
Kimberley A. Savage, Maria del Carmen Parquet, David Allan, et al.
Antimicrobial Agents and Chemotherapy (2018) Vol. 62, Iss. 8
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design
Brian C. Monk, A. Sagatova, Parham Hosseini, et al.
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2019) Vol. 1868, Iss. 3, pp. 140206-140206
Closed Access | Times Cited: 95
Siderophore Production by Rhizosphere Biological Control Bacteria Brevibacillus brevis GZDF3 of Pinellia ternata and Its Antifungal Effects on Candida albicans
Miao miao Sheng, Hua ke Jia, Gong you Zhang, et al.
Journal of Microbiology and Biotechnology (2020) Vol. 30, Iss. 5, pp. 689-699
Open Access | Times Cited: 55
Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration
Xueyang Jin, Ming Zhang, Jinghui Lu, et al.
Journal of Advanced Research (2021) Vol. 34, pp. 65-77
Open Access | Times Cited: 47
Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox
Aidan Kane, Dee Carter
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 482-482
Open Access | Times Cited: 30
A New Phenotype in Candida -Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains
Arianna Sala, Andrea Ardizzoni, Luca Spaggiari, et al.
mBio (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 15
Iron‐MOFs for Biomedical Applications
Zhihao Yu, Mathilde Lepoitevin, Christian Serre
Advanced Healthcare Materials (2024)
Open Access | Times Cited: 6
Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis
Jessie MacAlpine, Michail S. Lionakis
Cell Host & Microbe (2024) Vol. 32, Iss. 10, pp. 1654-1667
Closed Access | Times Cited: 5
Modulation of Iron Metabolism in Response to Infection: Twists for All Tastes
Ana Cordeiro Gomes, Ana C. Moreira, Gonçalo Mesquita, et al.
Pharmaceuticals (2018) Vol. 11, Iss. 3, pp. 84-84
Open Access | Times Cited: 44
Iron Chelator Deferasirox Reduces Candida albicans Invasion of Oral Epithelial Cells and Infection Levels in Murine Oropharyngeal Candidiasis
Sumant Puri, Rohitashw Kumar, Isolde G. Rojas, et al.
Antimicrobial Agents and Chemotherapy (2019) Vol. 63, Iss. 4
Open Access | Times Cited: 41
Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro
Maria del Carmen Parquet, Kimberley A. Savage, David Allan, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 39
Iron alters the cell wall composition and intracellular lactate to affect Candida albicans susceptibility to antifungals and host immune response
Aparna Tripathi, Elisabetta Liverani, Alexander Y. Tsygankov, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 29, pp. 10032-10044
Open Access | Times Cited: 38
Methicillin-resistant Staphylococcus pseudintermedius: epidemiological changes, antibiotic resistance, and alternative therapeutic strategies
Francesca Paola Nocera, Luisa De Martino
Veterinary Research Communications (2024) Vol. 48, Iss. 6, pp. 3505-3515
Open Access | Times Cited: 4
DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity
M. Trisha C. Ang, Roger Gumbau‐Brisa, David Allan, et al.
MedChemComm (2018) Vol. 9, Iss. 7, pp. 1206-1212
Open Access | Times Cited: 38
Candida albicans enhances iron uptake to maintain fluconazole resistance
Rishabh Sharma, Anubhav Nahar, Sumant Puri
Infection and Immunity (2025)
Open Access
Synthesis, characterization, and simulation of triazole-based MOFs in paracetamol-induced hepatotoxicity in rats with antimicrobial inspection
Maha B. Abd Elhaleem, Fatma M. Elantabli, S. M. Abbas, et al.
Inorganic Chemistry Communications (2025), pp. 114334-114334
Closed Access
Integrating ensemble machine learning and multi-omics approaches to identify Dp44mT as a novel anti-Candida albicans agent targeting cellular iron homeostasis
Xiaowei Chai, Yuanying Jiang, Hui Lü, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice
Maria del Carmen Parquet, Kimberley A. Savage, David Allan, et al.
Antimicrobial Agents and Chemotherapy (2019) Vol. 63, Iss. 9
Open Access | Times Cited: 26
Zinc and Iron Homeostasis: Target-Based Drug Screening as New Route for Antifungal Drug Development
Claudia Simm, Robin C. May
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 24
Pseudomonas Synergizes with Fluconazole against Candida during Treatment of Polymicrobial Infection
Siham Hattab, Anna-Maria Dagher, Robert T. Wheeler
Infection and Immunity (2022) Vol. 90, Iss. 4
Open Access | Times Cited: 13
The adaptive response to iron involves changes in energetic strategies in the pathogen Candida albicans
Celia Duval, Carole Macabiou, Camille Garcia, et al.
MicrobiologyOpen (2019) Vol. 9, Iss. 2
Open Access | Times Cited: 21
Candida albicansreprioritizes metal handling during fluconazole stress
Elizabeth W. Hunsaker, Katherine J. Franz
Metallomics (2019) Vol. 11, Iss. 12, pp. 2020-2032
Open Access | Times Cited: 20
Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles’ heel of antibiotic-resistant microbes
Bruce E. Holbein, M. Trisha C. Ang, David Allan, et al.
Environmental Chemistry Letters (2021) Vol. 19, Iss. 4, pp. 2789-2808
Open Access | Times Cited: 18
Comparison of Treatment Effects of Different Iron Chelators in Experimental Models of Sepsis
Christine Lehmann, Maral Aali, Juan Zhou, et al.
Life (2021) Vol. 11, Iss. 1, pp. 57-57
Open Access | Times Cited: 17
Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria
Natalia V. Kirienko, Laurence G. Rahme, You‐Hee Cho
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 18
Synergistic Effect of the Combination of Deferoxamine and Fluconazole In Vitro and In Vivo against Fluconazole-Resistant Candida Spp.
Lulu An, Jingwen Tan, Yuanyuan Wang, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 11
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top